Whipplewood Advisors, LLC Novartis Ag Transaction History
Whipplewood Advisors, LLC
- $169 Billion
- Q1 2025
A detailed history of Whipplewood Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 1,617 shares of NVS stock, worth $175,379. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,617
Previous 1,497
8.02%
Holding current value
$175,379
Previous $146 Million
20.22%
% of portfolio
0.1%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,522Shares Held
142MCall Options Held
1.53MPut Options Held
1.79M-
Dodge & Cox San Francisco, CA11.8MShares$1.28 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.13 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$933 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$765 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$734 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...